{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:13:31Z","timestamp":1773076411805,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Research Foundation funded by the Korea government","award":["Project No. NRF-2017R1C1B2009158"],"award-info":[{"award-number":["Project No. NRF-2017R1C1B2009158"]}]},{"name":"the Korea Health Technology R&D Project, Ministry of Health and Welfare","award":["Project No. HI15C0377"],"award-info":[{"award-number":["Project No. HI15C0377"]}]},{"name":"the Asan Institute for Life Sciences","award":["Project no. 2016-347"],"award-info":[{"award-number":["Project no. 2016-347"]}]},{"name":"Dong-A ST"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00198-019-04871-5","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T10:36:26Z","timestamp":1549276586000},"page":"1059-1069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism"],"prefix":"10.1007","volume":"30","author":[{"given":"S.H.","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Y.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.-J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-3677","authenticated-orcid":false,"given":"J.-M.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-H.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"4871_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175:G1\u2013g34. \n                    https:\/\/doi.org\/10.1530\/eje-16-0467","journal-title":"Eur J Endocrinol"},{"key":"4871_CR2","doi-asserted-by":"publisher","first-page":"M61","DOI":"10.1530\/EJE-15-0272","volume":"173","author":"G Dalmazi Di","year":"2015","unstructured":"Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M (2015) Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol 173:M61\u2013M71. \n                    https:\/\/doi.org\/10.1530\/eje-15-0272","journal-title":"Eur J Endocrinol"},{"key":"4871_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2010-2722","volume":"96","author":"I Chiodini","year":"2011","unstructured":"Chiodini I (2011) Clinical review: diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223\u20131236. \n                    https:\/\/doi.org\/10.1210\/jc.2010-2722","journal-title":"J Clin Endocrinol Metab"},{"key":"4871_CR4","doi-asserted-by":"publisher","first-page":"R265","DOI":"10.1530\/EJE-16-0289","volume":"175","author":"I Chiodini","year":"2016","unstructured":"Chiodini I, Vainicher CE, Morelli V, Palmieri S, Cairoli E, Salcuni AS, Copetti M, Scillitani A (2016) Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review. Eur J Endocrinol 175:R265\u2013r282. \n                    https:\/\/doi.org\/10.1530\/eje-16-0289","journal-title":"Eur J Endocrinol"},{"key":"4871_CR5","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1093\/hmg\/ddr386","volume":"20","author":"J Fu","year":"2011","unstructured":"Fu J, Festen EA, Wijmenga C (2011) Multi-ethnic studies in complex traits. Hum Mol Genet 20:R206\u2013R213. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddr386","journal-title":"Hum Mol Genet"},{"key":"4871_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2362.2010.02330.x","volume":"40","author":"V Morelli","year":"2010","unstructured":"Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P, Chiodini I (2010) Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. Eur J Clin Investig 40:803\u2013811. \n                    https:\/\/doi.org\/10.1111\/j.1365-2362.2010.02330.x","journal-title":"Eur J Clin Investig"},{"key":"4871_CR7","doi-asserted-by":"publisher","first-page":"E293","DOI":"10.1210\/jc.2013-1418","volume":"99","author":"H Siggelkow","year":"2014","unstructured":"Siggelkow H, Etmanski M, Bozkurt S, Grobeta P, Koepp R, Brockmoller J, Tzvetkov MV (2014) Genetic polymorphisms in 11beta-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis. J Clin Endocrinol Metab 99:E293\u2013E302. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1418","journal-title":"J Clin Endocrinol Metab"},{"key":"4871_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jsbmb.2010.11.009","volume":"123","author":"A Szappanos","year":"2011","unstructured":"Szappanos A, Patocs A, Gergics P, Bertalan R, Kerti A, Acs B, Feldmann K, Racz K, Toth M (2011) The 83,557insA variant of the gene coding 11beta-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing\u2019s syndrome. J Steroid Biochem Mol Biol 123:79\u201384. \n                    https:\/\/doi.org\/10.1016\/j.jsbmb.2010.11.009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4871_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1530\/EJE-07-0137","volume":"157","author":"L Tauchmanova","year":"2007","unstructured":"Tauchmanova L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A (2007) Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. Eur J Endocrinol 157:359\u2013366. \n                    https:\/\/doi.org\/10.1530\/eje-07-0137","journal-title":"Eur J Endocrinol"},{"key":"4871_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cen.13145","volume":"86","author":"SH Lee","year":"2017","unstructured":"Lee SH, Song KH, Kim J, Park S, Ahn SH, Kim H, Cho YY, Suh S, Kim BJ, Kim JH, Koh JM (2017) New diagnostic criteria for subclinical hypercortisolism using postsurgical hypocortisolism: the co-work of adrenal research study. Clin Endocrinol 86:10\u201318. \n                    https:\/\/doi.org\/10.1111\/cen.13145","journal-title":"Clin Endocrinol"},{"key":"4871_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.5650100403","volume":"10","author":"D Kiel","year":"1995","unstructured":"Kiel D (1995) Assessing vertebral fractures. National Osteoporosis Foundation Working Group on Vertebral Fractures. J Bone Miner Res 10:518\u2013523. \n                    https:\/\/doi.org\/10.1002\/jbmr.5650100403","journal-title":"J Bone Miner Res"},{"key":"4871_CR12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148. \n                    https:\/\/doi.org\/10.1002\/jbmr.5650080915","journal-title":"J Bone Miner Res"},{"key":"4871_CR13","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3758\/s13428-012-0289-7","volume":"45","author":"B Weaver","year":"2013","unstructured":"Weaver B, Wuensch KL (2013) SPSS and SAS programs for comparing Pearson correlations and OLS regression coefficients. Behav Res Methods 45:880\u2013895. \n                    https:\/\/doi.org\/10.3758\/s13428-012-0289-7","journal-title":"Behav Res Methods"},{"key":"4871_CR14","first-page":"785","volume":"285","author":"NIH Consensus Development Panel on","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis prevention, diagnosis, and therapy (2001) Osteoporosis prevention, diagnosis, and therapy JAMA 285:785\u2013795","journal-title":"Osteoporosis prevention, diagnosis, and therapy JAMA"},{"key":"4871_CR15","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1210\/jc.2009-0468","volume":"94","author":"I Chiodini","year":"2009","unstructured":"Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94:3207\u20133214. \n                    https:\/\/doi.org\/10.1210\/jc.2009-0468","journal-title":"J Clin Endocrinol Metab"},{"key":"4871_CR16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0394-0","journal-title":"Osteoporos Int"},{"key":"4871_CR17","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1210\/jcem.86.11.8022","volume":"86","author":"I Chiodini","year":"2001","unstructured":"Chiodini I, Torlontano M, Carnevale V, Guglielmi G, Cammisa M, Trischitta V, Scillitani A (2001) Bone loss rate in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab 86:5337\u20135341. \n                    https:\/\/doi.org\/10.1210\/jcem.86.11.8022","journal-title":"J Clin Endocrinol Metab"},{"key":"4871_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1046\/j.1365-2265.2003.01676.x","volume":"58","author":"D Hadjidakis","year":"2003","unstructured":"Hadjidakis D, Tsagarakis S, Roboti C (2003) Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin Endocrinol 58:72\u201377","journal-title":"Clin Endocrinol"},{"key":"4871_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0248-8663(02)00606-9","volume":"23","author":"S Bardet","year":"2002","unstructured":"Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A (2002) Bone density and biochemical bone markers in patients with adrenal incidentalomas: effect of subclinical hypercortisolism. Rev Med Interne 23:508\u2013517","journal-title":"Rev Med Interne"},{"key":"4871_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1210\/jc.2016-2718","volume":"102","author":"MC Dennedy","year":"2017","unstructured":"Dennedy MC, Annamalai AK, Prankerd-Smith O, Freeman N, Vengopal K, Graggaber J, Koulouri O, Powlson AS, Shaw A, Halsall DJ, Gurnell M (2017) Low DHEAS: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas. J Clin Endocrinol Metab 102:786\u2013792. \n                    https:\/\/doi.org\/10.1210\/jc.2016-2718","journal-title":"J Clin Endocrinol Metab"},{"key":"4871_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cen.12755","volume":"83","author":"D Lee","year":"2015","unstructured":"Lee D, Kim H, Ahn SH, Lee SH, Bae SJ, Kim EH, Kim HK, Choe JW, Kim BJ, Koh JM (2015) The association between serum dehydroepiandrosterone sulphate (DHEA-S) level and bone mineral density in Korean men. Clin Endocrinol 83:173\u2013179. \n                    https:\/\/doi.org\/10.1111\/cen.12755","journal-title":"Clin Endocrinol"},{"key":"4871_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.11005\/jbm.2017.24.1.31","volume":"24","author":"SG Park","year":"2017","unstructured":"Park SG, Hwang S, Kim JS, Park KC, Kwon Y, Kim KC (2017) The association between dehydroepiandrosterone sulfate (DHEA-S) and bone mineral density in Korean men and women. J Bone Metab 24:31\u201336. \n                    https:\/\/doi.org\/10.11005\/jbm.2017.24.1.31","journal-title":"J Bone Metab"},{"key":"4871_CR23","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00198-004-1616-3","volume":"15","author":"M Minetto","year":"2004","unstructured":"Minetto M, Reimondo G, Osella G, Ventura M, Angeli A, Terzolo M (2004) Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing\u2019s syndrome. Osteoporos Int 15:855\u2013861. \n                    https:\/\/doi.org\/10.1007\/s00198-004-1616-3","journal-title":"Osteoporos Int"},{"key":"4871_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1507\/endocrj.50.1","volume":"50","author":"N Ohmori","year":"2003","unstructured":"Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing\u2019s syndrome. Endocr J 50:1\u20137","journal-title":"Endocr J"},{"key":"4871_CR25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJM199502023320506","volume":"332","author":"SC Manolagas","year":"1995","unstructured":"Manolagas SC, Jilka RL (1995) Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305\u2013311. \n                    https:\/\/doi.org\/10.1056\/NEJM199502023320506","journal-title":"N Engl J Med"},{"key":"4871_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1530\/eje.0.1450241","volume":"145","author":"L Tauchmanova","year":"2001","unstructured":"Tauchmanova L, Rossi R, Nuzzo V, del Puente A, Esposito-del Puente A, Pizzi C, Fonderico F, Lupoli G, Lombardi G (2001) Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol 145:241\u2013247","journal-title":"Eur J Endocrinol"},{"key":"4871_CR27","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/jbmr.398","volume":"26","author":"V Morelli","year":"2011","unstructured":"Morelli V, Eller-Vainicher C, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I (2011) Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res 26:1816\u20131821. \n                    https:\/\/doi.org\/10.1002\/jbmr.398","journal-title":"J Bone Miner Res"},{"key":"4871_CR28","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/jbmr.1648","volume":"27","author":"C Eller-Vainicher","year":"2012","unstructured":"Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I (2012) Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27:2223\u20132230. \n                    https:\/\/doi.org\/10.1002\/jbmr.1648","journal-title":"J Bone Miner Res"},{"key":"4871_CR29","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00198-018-4608-4","volume":"29","author":"BJ Kim","year":"2018","unstructured":"Kim BJ, Kwak MK, Ahn SH, Kim JS, Lee SH, Koh JM (2018) The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion. Osteoporos Int 29:2299\u20132307. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4608-4","journal-title":"Osteoporos Int"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-04871-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:27:36Z","timestamp":1580758056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-04871-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["4871"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-04871-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"6 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}